These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 307109)
1. [Complications of antithrombotic prophylaxis with acetylsalicylic acid (ASS) in polycythemia (author's transl)]. Ranft K; Brands W Med Klin; 1978 Jun; 73(22):839-42. PubMed ID: 307109 [TBL] [Abstract][Full Text] [Related]
2. [Prevention of vascular complications in polycythemia vera and primary thrombocythemia treated with low doses of acetylsalicylic acid]. Fröhli P; Graf C; Rhyner K Schweiz Med Wochenschr; 1983 Nov; 113(44):1622-7. PubMed ID: 6685916 [TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients. Bachleitner-Hofmann T; Grumbeck E; Gisslinger H Thromb Res; 2003; 112(4):229-32. PubMed ID: 14987916 [TBL] [Abstract][Full Text] [Related]
4. [The antithrombotic treatment and prevention of recurrence with acetylsalicylic acid in myocardial infarct]. Heuchel G; Hässler W Z Gesamte Inn Med; 1976 Feb; 31(3):61-5. PubMed ID: 1085534 [TBL] [Abstract][Full Text] [Related]
5. [Optimation of postoperative prophylaxis of thrombosis in gynaecology (author's transl)]. Adolf J; Buttermann G; Weidenbach A; Gmeineder F Geburtshilfe Frauenheilkd; 1978 Feb; 38(2):98-104. PubMed ID: 631536 [TBL] [Abstract][Full Text] [Related]
6. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T; Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279 [TBL] [Abstract][Full Text] [Related]
7. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies. Landolfi R; Di Gennaro L; Novarese L; Patrono C Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279 [TBL] [Abstract][Full Text] [Related]
8. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia. Michiels JJ; Berneman Z; Schroyens W; van Urk H Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947 [TBL] [Abstract][Full Text] [Related]
9. A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP). Finazzi G; Pathol Biol (Paris); 2004 Jun; 52(5):285-8. PubMed ID: 15217715 [TBL] [Abstract][Full Text] [Related]
10. Polycythemia vera and mesenteric arterial thrombosis. A disease association resulting from decreased platelet sensitivity to aspirin. Myers TJ; Steinberg WM; Rickles FR Arch Intern Med; 1979 Jun; 139(6):695-8. PubMed ID: 443976 [TBL] [Abstract][Full Text] [Related]
11. Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy. Blackshear JL; Baker VS; Holland A; Litin SC; Ahlquist DA; Hart RG; Ellefson R; Koehler J Arch Intern Med; 1996 Mar; 156(6):658-60. PubMed ID: 8629878 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses]. Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739 [TBL] [Abstract][Full Text] [Related]
13. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Elliott MA; Tefferi A Br J Haematol; 2005 Feb; 128(3):275-90. PubMed ID: 15667529 [TBL] [Abstract][Full Text] [Related]
14. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention. Landolfi R; Cipriani MC; Novarese L Best Pract Res Clin Haematol; 2006; 19(3):617-33. PubMed ID: 16781491 [TBL] [Abstract][Full Text] [Related]
15. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis. Sarasin FP; Bounameaux H Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939 [TBL] [Abstract][Full Text] [Related]
16. [Gastrointestinal bleeding during low dose acetylsalicylic acid. Is Godamed-100 TAH an alternative to conventional ASS preparations?]. Maywald U; Schindler C Dtsch Med Wochenschr; 2005 Apr; 130(16):1026-7. PubMed ID: 15830316 [No Abstract] [Full Text] [Related]
17. Diagnosis and therapy of polycythemia vera. Lengfelder E; Merx K; Hehlmann R Semin Thromb Hemost; 2006 Apr; 32(3):267-75. PubMed ID: 16673281 [TBL] [Abstract][Full Text] [Related]
18. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy. Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469 [TBL] [Abstract][Full Text] [Related]
19. Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis. Büttner T; Hellwig K; Müller T; Kuhn W Clin Neuropharmacol; 1998; 21(1):48-51. PubMed ID: 9579285 [TBL] [Abstract][Full Text] [Related]
20. Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia data. Finazzi G Semin Thromb Hemost; 2006 Apr; 32(3):276-82. PubMed ID: 16673282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]